Literature DB >> 22814964

Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases.

Jean-Vannak Chauny1, Mathie Lorrot, Sonia Prot-Labarthe, Agathe De Lauzanne, Catherine Doit, Tina Géréral, Olivier Bourdon.   

Abstract

We report 6 pediatric cases of tuberculosis caused by Mycobacterium tuberculosis and treated them with levofloxacin or moxifloxacin in the mother-child unit of a university hospital in France between 2005 and 2011. We assess the clinical efficacy and safety of fluoroquinolones and the benefit-risk ratio for their use as second-line antituberculosis drugs in children and adolescents.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22814964     DOI： 10.1097/INF.0b013e318269cc6a

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  5 in total

1.  Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis.

Authors:  Stephanie Thee; Anthony J Garcia-Prats; Heather R Draper; Helen M McIlleron; Lubbe Wiesner; Sandra Castel; H Simon Schaaf; Anneke C Hesseling
Journal:  Clin Infect Dis       Date:  2014-10-30       Impact factor: 9.079

Review 2.  Safety Concerns Surrounding Quinolone Use in Children.

Authors:  Karisma Patel; Jennifer L Goldman
Journal:  J Clin Pharmacol       Date:  2016-03-28       Impact factor: 3.126

3.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

4.  The spread of drug-resistant tuberculosis in children: an Italian case series.

Authors:  F Mignone; L R Codecasa; C Scolfaro; I Raffaldi; L Lancella; M Ferrarese; S Garazzino; C Marabotto; S Esposito; C Gabiano; R Lipreri; P-A Tovo
Journal:  Epidemiol Infect       Date:  2013-12-19       Impact factor: 4.434

Review 5.  Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis.

Authors:  James A Seddon; H Simon Schaaf
Journal:  Pneumonia (Nathan)       Date:  2016-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.